Advertisement
Product › Details
Inositune™ platform
Next higher product group | drug discovery technology_oo | |
Status | 2016-10-27 existent | |
Organisation | Inositec AG | |
Group | Vifor Pharma (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for drug discovery technology_oo
- [1] Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren....
- [2] PeptiDream Inc.. (4/30/24). "Press Release: PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis". Kanagawa....
- [3] Neurolentech GmbH. (4/22/24). "Press Release: Neurolentech Signs Technology Access Partnership with Kaerus Bioscience to Advance Neurodevelopmental Disorder Research". Klosterneuburg....
- [4] BioCopy AG. (4/9/24). "Press Release: BioCopy Expands Corporate Portfolio with Acquisition of Perspix Biotech GmbH". Basel....
- [5] Nuclera Ltd.. (2/7/24). "Press Release: Nuclera Partners with Sharp Life Science Advancing Its Digital Microfluidics Capability"....
- [6] AC Immune S.A.. (12/15/23). "Press Release: AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO". Lausanne....
- [7] Roche. (12/4/23). "Press Release: Roche Enters into a Definitive Merger Agreement to Acquire Carmot Therapeutics, including Three Clinical Stage Assets with Best-in-class Potential in Obesity and Diabetes". Basel....
- [8] Bicycle Therapeutics plc. (10/30/23). "Press Release: Bicycle Therapeutics to Participate in Upcoming Investor Conferences". Cambridge....
- [9] Pieris Pharmaceuticals, Inc.. (8/17/23). "Press Release: Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific". Boston, MA....
- [10] Pieris Pharmaceuticals, Inc.. (7/18/23). "Press Release: Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring". Boston, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top